Total and specific fluid consumption as determinants of bladder cancer risk.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 16284957)

Published in Int J Cancer on April 15, 2006

Authors

Cristina M Villanueva1, Kenneth P Cantor, Will D King, Jouni J K Jaakkola, Sylvaine Cordier, Charles F Lynch, Stefano Porru, Manolis Kogevinas

Author Affiliations

1: Respiratory and Environmental Health Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain. cvillanueva@imim.es

Articles citing this

Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect (2007) 1.60

Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMC Cancer (2009) 1.03

Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol (2008) 0.99

DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer. Carcinogenesis (2010) 0.91

Late age (85 years or older) peak incidence of bladder cancer. J Urol (2008) 0.90

Genetic susceptibility to bladder cancer risk and outcome. Per Med (2011) 0.90

Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort. Am J Epidemiol (2012) 0.88

Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control (2008) 0.85

Non-alcoholic beverages and risk of bladder cancer in Uruguay. BMC Cancer (2007) 0.84

Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk. Br J Cancer (2013) 0.84

Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1. Int J Cancer (2013) 0.82

Relationship between bladder cancer and total fluid intake: a meta-analysis of epidemiological evidence. World J Surg Oncol (2014) 0.82

Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses. Eur J Epidemiol (2016) 0.79

Fluid intake and risk of bladder cancer in the Nurses' Health Studies. Int J Cancer (2014) 0.76

Evaluation of a bladder cancer cluster in a population of criminal investigators with the Bureau of Alcohol, Tobacco, Firearms and Explosives-part 1: the cancer incidence. J Environ Public Health (2012) 0.76

Total fluid consumption and risk of bladder cancer: a meta-analysis with updated data. Oncotarget (2017) 0.75

Predictive model for chloroform during disinfection of water for consumption, city of Montevideo. Environ Monit Assess (2014) 0.75

[Systemic oncological treatment of bladder cancer]. Wien Med Wochenschr (2007) 0.75

Articles by these authors

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91

Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69

Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol (2002) 5.81

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet (2005) 5.01

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA (2003) 4.01

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA (2011) 3.69

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol (2008) 3.60

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. Ann Intern Med (2012) 3.44

Nitrate in public water supplies and the risk of colon and rectum cancers. Epidemiology (2003) 3.39

Variation of breast cancer risk among BRCA1/2 carriers. JAMA (2008) 3.30

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07

Swimming pool attendance, asthma, allergies, and lung function in the Avon Longitudinal Study of Parents and Children cohort. Am J Respir Crit Care Med (2010) 3.02

Reliability of reporting on life-style and agricultural factors by a sample of participants in the Agricultural Health Study from Iowa. Epidemiology (2002) 3.00

Asthma and caries: a systematic review and meta-analysis. Am J Epidemiol (2011) 2.81

A combined analysis of North American case-control studies of residential radon and lung cancer. J Toxicol Environ Health A (2006) 2.78

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst (2007) 2.70

Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol (2002) 2.63

Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology (2005) 2.56

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet (2010) 2.56

Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol (2002) 2.51

A review of the literature on the effects of ambient air pollution on fetal growth. Environ Res (2004) 2.49

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49

Improved survival of follicular lymphoma patients in the United States. J Clin Oncol (2005) 2.46

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. Nat Genet (2013) 2.44

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst (2002) 2.44

A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst (2009) 2.40

Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am J Epidemiol (2003) 2.39

Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38

Disabling musculoskeletal pain in working populations: is it the job, the person, or the culture? Pain (2013) 2.38

Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus (2006) 2.25

A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J Allergy Clin Immunol (2011) 2.24

Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet (2013) 2.21

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol (2007) 2.17

The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol (2009) 2.16

Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv (2011) 2.15

Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study. J Clin Oncol (2013) 2.15

Where do patients with cancer in Iowa receive radiation therapy? J Oncol Pract (2014) 2.14

Sleep patterns in late pregnancy and risk of preterm birth and fetal growth restriction. Epidemiology (2011) 2.08

Chlordecone exposure, length of gestation, and risk of preterm birth. Am J Epidemiol (2014) 2.08

Epidemiologic association between prostatitis and prostate cancer. Urology (2002) 2.05

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res (2004) 2.03

Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res (2013) 1.99

Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax (2007) 1.98

Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet (2010) 1.97

Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology (2004) 1.97

Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol (2007) 1.96

Maternal pre-pregnancy overweight and obesity, and child neuropsychological development: two Southern European birth cohort studies. Int J Epidemiol (2013) 1.95

Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol (2005) 1.92

The faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol (2008) 1.91

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst (2010) 1.91

Meta-analysis of dioxin cancer dose response for three occupational cohorts. Environ Health Perspect (2003) 1.86

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol (2010) 1.85

Residential mobility during pregnancy. Paediatr Perinat Epidemiol (2004) 1.85

Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev (2006) 1.84

Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol (2006) 1.83

Smoking and smoking cessation during early pregnancy and its effect on adverse pregnancy outcomes and fetal growth. Eur J Pediatr (2009) 1.83

Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control (2010) 1.82

Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect (2010) 1.81

Cigarette smoking and cancer risk: modeling total exposure and intensity. Am J Epidemiol (2007) 1.80

The use of household cleaning sprays and adult asthma: an international longitudinal study. Am J Respir Crit Care Med (2007) 1.79

Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect (2011) 1.79

P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol (2005) 1.79

Birth weight, head circumference, and prenatal exposure to acrylamide from maternal diet: the European prospective mother-child study (NewGeneris). Environ Health Perspect (2012) 1.74

Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ Health Perspect (2004) 1.74

Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol (2006) 1.73

Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.72

Childhood asthma and environmental exposures at swimming pools: state of the science and research recommendations. Environ Health Perspect (2008) 1.71

Health promotion trials at worksites and risk factors for cancer. Scand J Work Environ Health (2002) 1.70

Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol (2008) 1.69

Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet (2007) 1.68

Environmental tobacco smoke and adult-onset asthma: a population-based incident case-control study. Am J Public Health (2003) 1.68

Socioeconomic status and asthma prevalence in young adults: the European Community Respiratory Health Survey. Am J Epidemiol (2004) 1.67

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood (2007) 1.63

Qualitative assessment of visuospatial errors in mercury-exposed Amazonian children. Neurotoxicology (2008) 1.62

Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect (2007) 1.60

Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60

Breastfeeding, exposure to organochlorine compounds, and neurodevelopment in infants. Pediatrics (2003) 1.59

Environmental and urinary markers of prenatal exposure to drinking water disinfection by-products, fetal growth, and duration of gestation in the PELAGIE birth cohort (Brittany, France, 2002-2006). Am J Epidemiol (2011) 1.59

European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet (2011) 1.58

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys (2008) 1.58

PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors. Cancer Res (2006) 1.57